Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials
![Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials image](https://healthtree.org/images-resize?width=1000&height=1000&imageUrl=https%253A%252F%252Ffirebasestorage.googleapis.com%252Fv0%252Fb%252Fhealthtree-production.appspot.com%252Fo%252Fgallery%25252Fpublic%25252Fclinical%252520trial%252520puzzle_dd5b2031-b393-4553-8f30-46aba6882678.jpg%253Falt%253Dmedia)
Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials
Event Description
This event will not be live-streamed; it will be recorded on March 29th. You can submit your questions in advance by clicking "notify when available" above and enter your question in the box. We will ask the submitted questions during the Q&A at the end.
In this podcast episode, Dr. Christopher Melani will share about three important trials he has been working on at The National Institute of Health in Bethesda, Maryland. The VVIP, VIPOR, and VIPOR-P studies are targeted therapy combinations that could be the future of lymphoma treatment. We will be discussing the trial designs, patient eligibility, and how these new treatments could improve lymphoma patient outcomes.
Thank you to our episode sponsor, Regeneron.
Schedule & Agenda
Speakers & Moderators
![The panelist Dr. Christopher Melani](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-15%20at%202.38.25%E2%80%AFPM_40bd9685-93fe-4922-b2a3-ba709fd5205d.png?alt=media)
Dr. Melani is a Staff Clinician and a clinical researcher specializing in lymphoma. His areas of interest include the use of novel therapies and drug combinations for the treatment of lymphomas as well as novel methods of molecular monitoring of disease and response to treatment, such as circulating tumor DNA (ctDNA).
![The panelist Kat Richardson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FKat_205dcbf3-d19c-4c3b-88b0-8f8b1d620abe.jpeg?alt=media)
Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Follicular lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Follicular Lymphoma Sponsors:
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_logo_(2).svg_64899492-87cd-4df9-9d4b-07f9618df890.png?alt=media)
![Bristol Myers Squibb](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FBristol%20Myers%20Squibb_f22fa9b6-b205-4828-bea5-d645566d3243.png?alt=media)